See Local News
Get Balanced News From Your U.S. State.
See Local News
See all locals

Zealand Pharma says drug shows improvement in fatty liver disease patients

Posted on AllSides June 6th, 2024
From The Center

June 6 (Reuters) - Denmark's Zealand Pharma (ZELA.CO) said on Thursday its experimental weight-loss drug showed an improvement in patients with a type of fatty liver disease after results from a mid-stage study were leaked, sending its shares up nearly 7%. The company said the data from the trial in patients with metabolic dysfunction-associated steatohepatitis (MASH) was unintentionally and temporarily leaked ahead of its scheduled release on Friday at the European Association for the Study of Liver Congress. A spokesperson for Zealand's German partner Boehringer Ingelheim said the full data...

Read full story

More News about Business from the Left, Center and Right

From the Left

From the Center

From the Right